Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 298

1.

Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.

Tram Henriksen L, Gottschalk Højfeldt S, Schmiegelow K, Frandsen TL, Skov Wehner P, Schrøder H, Klug Albertsen B; Nordic Society of Pediatric Hematology and Oncology, NOPHO Group.

Pediatr Blood Cancer. 2017 Jun 29. doi: 10.1002/pbc.26686. [Epub ahead of print]

PMID:
28660740
2.

EEG with extreme delta brush in young female with methotrexate neurotoxicity supports NMDA receptor involvement.

Schmidt LS, Kjær TW, Schmiegelow K, Born AP.

Eur J Paediatr Neurol. 2017 Jun 15. pii: S1090-3798(17)31685-9. doi: 10.1016/j.ejpn.2017.05.008. [Epub ahead of print]

PMID:
28655493
3.

Liposomal Cytarabine Induces Less Neurocognitive Dysfunction Than Intrathecal Methotrexate in an Animal Model.

Thomsen AM, Gulinello ME, Wen J, Schmiegelow K, Cole PD.

J Pediatr Hematol Oncol. 2017 Jun 26. doi: 10.1097/MPH.0000000000000888. [Epub ahead of print]

PMID:
28654460
4.

Cerebellar mutism syndrome in children with brain tumours of the posterior fossa.

Wibroe M, Cappelen J, Castor C, Clausen N, Grillner P, Gudrunardottir T, Gupta R, Gustavsson B, Heyman M, Holm S, Karppinen A, Klausen C, Lönnqvist T, Mathiasen R, Nilsson P, Nysom K, Persson K, Rask O, Schmiegelow K, Sehested A, Thomassen H, Tonning-Olsson I, Zetterqvist B, Juhler M.

BMC Cancer. 2017 Jun 21;17(1):439. doi: 10.1186/s12885-017-3416-0.

5.

Do cytogenetics of acute lymphoblastic leukaemia blasts affect required duration and intensity of maintenance therapy? - Authors' reply.

Schmiegelow K, Nielsen SN, Grell K.

Lancet Oncol. 2017 Jun;18(6):e292. doi: 10.1016/S1470-2045(17)30348-0. No abstract available.

PMID:
28593847
6.

Early presentation of osteonecrosis in acute lymphoblastic leukemia: Two children from the Nordic and Baltic cohort.

Mogensen SS, Harila-Saari A, Frandsen TL, Lähteenmäki P, Castor A, Kohonen I, Schmiegelow K, Mäkitie O.

Pediatr Blood Cancer. 2017 May 18. doi: 10.1002/pbc.26624. [Epub ahead of print]

PMID:
28521072
7.

Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers.

Nielsen SN, Eriksson F, Rosthoej S, Andersen MK, Forestier E, Hasle H, Hjalgrim LL, Aasberg A, Abrahamsson J, Heyman M, Jónsson ÓG, Pruunsild K, Vaitkeviciené GE, Vettenranta K, Schmiegelow K.

Pediatr Blood Cancer. 2017 May 13. doi: 10.1002/pbc.26518. [Epub ahead of print]

PMID:
28500740
8.

The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.

Moriyama T, Nishii R, Lin TN, Kihira K, Toyoda H, Jacob N, Kato M, Koh K, Inaba H, Manabe A, Schmiegelow K, Yang JJ, Hori H.

Pharmacogenet Genomics. 2017 Jun;27(6):236-239. doi: 10.1097/FPC.0000000000000282.

PMID:
28445187
9.

Childhood vaccinations and risk of acute lymphoblastic leukaemia in children.

Søegaard SH, Rostgaard K, Schmiegelow K, Kamper-Jørgensen M, Hargreave M, Hjalgrim H, Hviid A.

Int J Epidemiol. 2017 Apr 19. doi: 10.1093/ije/dyx052. [Epub ahead of print]

PMID:
28431124
10.

Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.

Toksvang LN, De Pietri S, Nielsen SN, Nersting J, Albertsen BK, Wehner PS, Rosthøj S, Lähteenmäki PM, Nilsson D, Nystad TA, Grell K, Frandsen TL, Schmiegelow K.

Pediatr Blood Cancer. 2017 Apr 19. doi: 10.1002/pbc.26519. [Epub ahead of print]

PMID:
28423235
11.

Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.

Schmiegelow K, Müller K, Mogensen SS, Mogensen PR, Wolthers BO, Stoltze UK, Tuckuviene R, Frandsen T.

F1000Res. 2017 Apr 7;6:444. doi: 10.12688/f1000research.10768.1. eCollection 2017. Review.

12.

DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.

Nielsen SN, Grell K, Nersting J, Abrahamsson J, Lund B, Kanerva J, Jónsson ÓG, Vaitkeviciene G, Pruunsild K, Hjalgrim LL, Schmiegelow K.

Lancet Oncol. 2017 Apr;18(4):515-524. doi: 10.1016/S1470-2045(17)30154-7. Epub 2017 Mar 1.

PMID:
28258828
13.

Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.

Mogensen SS, Schmiegelow K, Grell K, Albertsen BK, Wehner PS, Kampmann P, Frandsen TL.

Haematologica. 2017 May;102(5):e175-e178. doi: 10.3324/haematol.2016.160507. Epub 2017 Feb 16. No abstract available.

14.

FAMily-Oriented Support (FAMOS): development and feasibility of a psychosocial intervention for families of childhood cancer survivors.

Salem H, Johansen C, Schmiegelow K, Winther JF, Wehner PS, Hasle H, Rosthøj S, Kazak AE, E Bidstrup P.

Acta Oncol. 2017 Feb;56(2):367-374. doi: 10.1080/0284186X.2016.1269194. Epub 2017 Jan 12.

PMID:
28080169
15.

Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia.

Ebbesen MS, Nygaard U, Rosthøj S, Sørensen D, Nersting J, Vettenranta K, Wesenberg F, Kristinsson J, Harila-Saari A, Schmiegelow K.

J Pediatr Hematol Oncol. 2017 Apr;39(3):161-166. doi: 10.1097/MPH.0000000000000733.

PMID:
28060115
16.

Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.

Svahn T, Mellgren K, Harila-Saari A, Åsberg A, Kanerva J, Jónsson Ó, Vaitkeviciene G, Stamm Mikkelssen T, Schmiegelow K, Heldrup J.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26395. Epub 2016 Dec 14.

PMID:
27966809
17.

Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia.

Nielsen SN, Grell K, Nersting J, Frandsen TL, Hjalgrim LL, Schmiegelow K.

Cancer Chemother Pharmacol. 2016 Nov;78(5):983-994. Epub 2016 Sep 6.

PMID:
27600880
18.

Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.

Levinsen M, Harila-Saari A, Grell K, Jonsson OG, Taskinen M, Abrahamsson J, Vettenranta K, Åsberg A, Risteli J, Heldrup J, Schmiegelow K.

J Pediatr Hematol Oncol. 2016 Nov;38(8):602-609.

PMID:
27571129
19.

Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?

Schmiegelow K, Nersting J, Nielsen SN, Heyman M, Wesenberg F, Kristinsson J, Vettenranta K, Schrøeder H, Weinshilboum R, Jensen KL, Grell K, Rosthoej S.

Pediatr Blood Cancer. 2016 Dec;63(12):2104-2111. doi: 10.1002/pbc.26139. Epub 2016 Jul 22.

PMID:
27447547
20.

Varicella Vaccination of Children With Leukemia Without Interruption of Maintenance Therapy: A Danish Experience.

Smedegaard LM, Poulsen A, Kristensen IA, Rosthøj S, Schmiegelow K, Nygaard U.

Pediatr Infect Dis J. 2016 Nov;35(11):e348-e352.

PMID:
27753768

Supplemental Content

Loading ...
Support Center